New Mutations Causing the Premature Termination of Translation in the A Subunit Gene of Coagulation Factor XIII

Summary

The amplification of factor XIIIA subunit gene exons and heteroduplex analysis has been used to identify two new mutations that cause severe factor XIII deficiency. One mutation in a family of French origin results from a 4 bp deletion and leads to a premature termination of translation. The other mutation occurred in a Turkish family and results from a C → T transition that inserts a premature translation stop signal at codon 400. Both mutations alter restriction enzyme sites and can be readily detected in amplified exon DNA for genetic counselling or prenatal diagnosis. The new mutations reflect the extensive molecular heterogeneity of factor XIII deficiency.

• References

• 1 Board PG, Losowsky MS, Miloszewski KJA. Factor XIII: Inherited and acquired deficiency. Blood Rev 1993; 7: 229-242
• 2 Schwartz ML, Pizzo SV, Hill RL, McKee PA. Human factor XIII from plasma and platelets. J Biol Chem 1973; 248: 1395-1407
• 3 Board PG. Genetic polymorphism of the A subunit of human coagulation factor XIII. Am J Hum Genet 1979; 31: 116-124
• 4 Board PG. Genetic polymorphism of the B subunit of human coagulation factor XIII. Am J Hum Genet 1980; 32: 348-353
• 5 Mary A, Achyuthan KE, Greenberg CS. β-chains prevent the proteolytic inactivation of the a-chains of plasma Factor XIII. Biochim Biophys Acta 1988; 966: 328-335
• 6 Bohn H. Comparative studies on the fibrin-stabilizing factors from human plasma, platelets and placentas. Ann New York Acad Sci 1972; 202: 256-272
• 7 Muszbek L, Adany R, Szegedi G, Polgar J, Kavai M. Factor XIII of blood coagulation in human monocytes. Thromb Res 1985; 37: 401-410
• 8 Adany R, Belkin A, Vasilevskaya T, Muszbek L. Identification of blood coagulation factor XIII in human peritoneal macrophages. Eur J Cell Biol 1985; 38: 171-173
• 9 Board PG, Webb GC, McKee J, Ichinose A. Localization of the coagulation Factor XIIIA subunit gene (FI3A) to chromosome bands 6p24>p25. Cyto-gen Cell Genet 1986; 48: 25-27
• 10 Webb GC, Coggan M, Ichinose A, Board PG. Localization of human coagulation Factor XIIIB subunit gene (FOB) to chromosome bands lq31-32.1 and restriction fragment polymorphism of the locus. Hum Genet 1989; 81: 157-160
• 11 Duckert F, Jung E, Shmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilising factor deficiency. Thromb Diath Haemorr 1960; 5: 179-186
• 12 Board P, Coggan M, Miloszewski K. Identification of a point mutation in Factor XIIIA subunit deficiency. Blood 1992; 80: 937-941
• 13 Kamura T, Okamura T, Murakawa M, Tsuda H, Teshima T, Shibuya T, Harada M, Niho Y. Deficiency of coagulation Factor XIIIA subunit caused by the dinucleotide deletion at the 5’ end of exon III. J Clin Invest 1992; 90: 315-319
• 14 Standen GR, Bowen DJ. Factor XIII A_{Bristol 1}: detection of a nonsense mutation (Arg¹⁷¹→stop codon) in factor XIIIA subunit deficiency. Br J Haematol 1993; 85: 769-772
• 15 Mikkola H, Syrjala M, Rasi V, Vahtera E, Hamalainen E, Peltonen L, Palotie A. Deficiency in the A-subunit of coagulation Factor XIII: Two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84: 517-525
• 16 Coggan M, Baker R, Miloszewski K, Woodfield G, Board P. Mutations causing coagulation Factor XIII subunit A deficiency: Characterization of the mutant proteins after expression in yeast. Blood 1995; 85: 2455-2460
• 17 Vreken P, Niessen RWLM, Peters M, Schaap MCL, Zuithoffrijntjes JGM, Sturk A. A point mutation in an invariant splice acceptor site results in a decreased mRNA level in a patient with severe coagulation factor XIII subunit A deficiency. Throm Haemost 1995; 74: 584-589
• 18 Aslam S, Poon MC, Yee VC, Bowen DJ, Standen GR. Factor XIIIA Calgary: a candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIA subunit. Br J Haematol 1995; 91: 452-457
• 19 Anwar R, Stewart AD, Miloszewski KJA, Losowsky MS, Markham AF. Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function. Br J Haematol 1995; 91: 728-735
• 20 White MB, Carvalho M, Derse D, O’Brien SJ, Dean M. Detecting single base substitutions as heteroduplex polymorphisms. Genomics 1992; 12: 301-306
• 21 Ichinose A, Davie EW. Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci USA 1988; 85: 5829-5833
• 22 Takahashi N, Takahashi Y, Putnam FW. Primary structure of blood coagulation factor XIII (fibrinoligase, transglutaminase) from human placenta. Proc Natl Acad Sci USA 1986; 83: 8019-8023
• 23 Emmerich J, Chadeuf G, Alhenc-Gelas M, Gouault-Heilman M, Toulon P, Fiessinger JN, Aiach M. Molecular basis of antithrombin type I deficiency: The first large in-frame deletion and two novel mutations in exon 6. Thromb Haemost 1994; 72: 534-539
• 24 Chun K, MacKay N, Petrova-Benedict R, Robinson BH. Mutations in the X-linked Ela subunit of pyruvate dehydrogenase leading to deficiency of the pyruvate dehydrogenase complex. Hum Mol Genet 1993; 2: 449-454
• 25 Efstratiadis A, Posakony JW, Maniatis T, Lawn R, O’Connell C, Spritz RA, De Riel JL, Forget BG, Weissman SM, Slightom JL, Blechl AE, Smithies O, Baralle FE, Shoulders CC, Proudfoot NJ. The structure and evolution of the human β-globin gene family. Cell 1980; 21: 653-668
• 26 Britten AFH. Congenital deficiency of factor XIII (fibrin-stabilizing factor). Am J Med 1967; 43: 751-761
• 27 Duckert F. Documentation of the plasma factor XIII deficiency in man. Ann New York Acad Sci 1972; 202: 190-199
• 28 Yee VC, Pedersen LC, Le-Trong I, Bishop PD, Stenkamp RE, Teller DC. Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc Natl Acad Sci USA 1994; 91: 7296-7300
• 29 Woodcock DM, Crowther PJ, Jefferson S, Diver WP. Methylation at dinucleotides other than CpG: implication for human maintenance methylation. Gene 1988; 74: 151-152